Picture of Indivior logo

INDV Indivior News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

REG - Indivior PLC - Transaction in Own Shares

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250114:nRSN1400Ta&default-theme=true

RNS Number : 1400T  Indivior PLC  14 January 2025

INDIVIOR PLC

SHARE REPURCHASE PROGRAM

WEEKLY REPORT

January 14, 2025

INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total
of 194,876 of its ordinary shares of $0.50 each through Morgan Stanley &
Co. International Plc in the period from January 6, 2024, up to and including
January 10, 2025, in connection with its $100m Share Repurchase Program.
Aggregated information on the purchase of these shares can be found in the
table below.

Following the purchase and cancellation of the above shares (including those
purchased but not yet settled), Indivior has 124,633,727 ordinary shares of
$0.50 each with voting rights in issue. There are no shares held in treasury.

The above figure (124,633,727) may be used by shareholders (and others with
notification obligations) as the denominator for the calculation by which they
will determine if they are required to notify their interest in, or a change
to their interest in, Indivior under the FCA's Disclosure Guidance and
Transparency Rules.

All repurchases by Indivior are "On Exchange" transactions (as such term is
defined in the rules of the London Stock Exchange) and "on market" for the
purposes of the Companies Act 2006.

Aggregated information

 Trading Date  Trading Venue  Aggregated daily volume (number of shares)  Daily weighted average purchase price of the shares (p)
 06/01/2025    LSE            16,616                                      1,000.29
 06/01/2025    BATE           3,315                                       998.31
 06/01/2025    CHIX           14,842                                      1,002.78
 06/01/2025    AQUIS          3,008                                       986.27
 07/01/2025    LSE            15,525                                      960.18
 07/01/2025    BATE           4,814                                       962.81
 07/01/2025    CHIX           16,484                                      959.91
 07/01/2025    AQUIS          2,262                                       962.54
 08/01/2025    LSE            14,400                                      973.59
 08/01/2025    BATE           8,461                                       972.32
 08/01/2025    CHIX           13,838                                      970.18
 08/01/2025    AQUIS          1,886                                       968.28
 09/01/2025    LSE            12,427                                      979.10
 09/01/2025    BATE           6,265                                       980.81
 09/01/2025    CHIX           19,824                                      980.46
 09/01/2025    AQUIS          895                                         979.90
 10/01/2025    LSE            17,670                                      973.98
 10/01/2025    BATE           6,914                                       973.89
 10/01/2025    CHIX           13,796                                      974.69
 10/01/2025    AQUIS          1,634                                       974.90

 

 

Transaction details

In accordance with Article 5(1)(b) of the assimilated Market Abuse Regulation
(EU) No 596/2014, as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018 and Commission Delegated Regulation (EU)
2016/1052, a full breakdown of the individual purchases of ordinary shares
made by Morgan Stanley & Co. International Plc on behalf of Indivior
during the above period as part of the Share Repurchase Program can be found
at
www.indivior.com/en/investors/shareholder-information/share-repurchase-program
(http://www.indivior.com/en/investors/shareholder-information/share-repurchase-program)
.

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

Contact:

Jason Thompson

Vice President, Investor Relations

1-804-402-7123

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSDZGMMVFVGKZM

Recent news on Indivior

See all news